EPIVIR HBV is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Lamivudine.
| Product ID | 0173-0662_4909c2fe-d6d5-4980-80ec-8ef0ff9ed574 |
| NDC | 0173-0662 |
| Product Type | Human Prescription Drug |
| Proprietary Name | EPIVIR HBV |
| Generic Name | Lamivudine |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 1998-12-17 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021003 |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | LAMIVUDINE |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1998-12-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021003 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-12-17 |
| Ingredient | Strength |
|---|---|
| LAMIVUDINE | 100 mg/1 |
| SPL SET ID: | 2df7349c-f5d7-47b5-d29b-1b6b31985591 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 53808-0893 | EPIVIR HBV | EPIVIR HBV |
| 0173-0662 | EPIVIR | lamivudine |
| 0173-0663 | EPIVIR | lamivudine |
| 21695-367 | EPIVIR | lamivudine |
| 49702-203 | EPIVIR | lamivudine |
| 49702-204 | EPIVIR | lamivudine |
| 49702-205 | EPIVIR | lamivudine |
| 50090-0550 | EPIVIR | lamivudine |
| 0904-6583 | LAMIVUDINE | lamivudine |
| 10135-605 | Lamivudine | Lamivudine |
| 31722-001 | lamivudine | lamivudine |
| 31722-752 | Lamivudine | Lamivudine |
| 31722-753 | Lamivudine | Lamivudine |
| 31722-754 | Lamivudine | Lamivudine |
| 33342-001 | Lamivudine | Lamivudine |
| 33342-002 | Lamivudine | Lamivudine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EPIVIR 78906783 3227835 Live/Registered |
VIIV HEALTHCARE COMPANY 2006-06-13 |
![]() EPIVIR 74213040 1981308 Live/Registered |
VIIV HEALTHCARE COMPANY 1991-10-11 |